Showing results (3341-3350 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|July 27, 2024
Pharmacogenomic Polygenic Model of Clopidogrel Predicts Recurrent Ischemic Events in Chinese Patients With Coronary Artery DiseaseXinyi Zhang, Yuchun Cai, Pei Zhou, et al.
Clinical Therapeutics|May 19, 2024
5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case ReportAdela Penesova, Peter Minarik, Miroslava Huckova, et al.
Clinical Therapeutics|May 23, 2024
Venetoclax Clinical Pharmacokinetics After Administration of Crushed, Ground or Whole TabletsSamaneh Alaei, Yamin Wang, Yueli Liu, et al.
Clinical Therapeutics|November 24, 2025
Evaluation of Colorectal Cancer Incidence in the United States From 2021 to 2024 Using a National Multi-Payer Claims DatabaseMallik Greene, Shrey Gohil, Brad Stieber, et al.
Clinical Therapeutics|April 26, 2024
Knowledge Graphs in Pharmacovigilance: A Step-By-Step GuideManfred Hauben, Mazin Rafi
Clinical Therapeutics|December 24, 2023
Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility StudyJames Lok, Maria Fernanda Guerra Veloz, Ruth Byrne, et al.
Clinical Therapeutics|December 15, 2023
Cardiovascular Adverse Events Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Therapy: A Systematic Review and Meta-analysisEkaterina Proskuriakova, Dhan Bahadur Shrestha, Ranjit Jasaraj, et al.
Clinical Therapeutics|January 14, 2024
First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-world Clinical Settings in a Middle East PopulationSajid Iqbal, Hani Mohamed Sabbour, Tanveer Ashraf, et al.
Clinical Therapeutics|January 2, 2024
Partnering for Better Health: Using Continuous Glucose Monitoring and Clinical Pharmacist Collaboration to Improve Glycemic Control in Underserved Patients With Type 2 DiabetesJason Powell, Shaunak R Mulani
Clinical Therapeutics|October 14, 2003
Type 2 diabetes, cardiovascular risk, and the link to insulin resistanceMark W Stolar, Robert J Chilton
Pageof 680